FEATURED

Height and Melanoma Risk

A recent study linked childhood height to risk of melanoma, but the findings should be interpreted with caution.

Metastasis More than Doubles With Monitoring

Contrary to some news headlines, monitoring prostate cancer has different survival implications than treatment after 10 years.

RT, Immunotherapy for Melanoma Brain Metastases

The combination of radiotherapy and immunotherapy for brain metastases is promising, though toxicity and timing are poorly-understood factors.

Defibrotide for Hepatic Sinusoidal Obstruction Syndrome

Hepatic sinusoidal obstruction syndrome is a challenging post-hematopoietic cell transplantation condition to both diagnose and to treat.

Breast Cancer: Advances in HER2 Role

Chapter 3: Drs. O’Shaughnessy and colleagues discuss the most exciting advances in the biologic role of HER2 in metastatic breast cancer.

Q&A With Samanta Kumar Pal, MD

In this Q&A, CTA asked Dr Pal about the ongoing controversy, evidence base, and pivotal studies of intermittent versus continuous androgen deprivation therapy for prostate cancer.

Multiple Myeloma: Emerging Prognostic Markers

Newly-discovered and future biomarkers are likely to help oncologists give an accurate prognosis and to prescribe more effective treatment for patients with multiple myeloma.

New Video Series: R/R Hodgkin Lymphoma

Jeffrey Schriber, MD, FRCP, Cancer Transplant Institute of Arizona Oncology Scottsdale, Arizona

Endocrine Therapy Continuation Beyond 5 Years?

Using case studies, experts discuss the Breast Cancer Index<sup>SM</sup> as a tool for clinicians and patients considering extended adjuvant endocrine therapy for early-stage ER+ breast cancer.

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Latest Features

Height and Melanoma Risk: What's the Takeaway?

Height and Melanoma Risk: What's the Takeaway?

A recent study linked childhood height to risk of melanoma, but the findings should be interpreted with caution.

Metastasis More than Doubles With Monitoring Instead of Treatment for Localized Prostate Cancer

Metastasis More than Doubles With Monitoring Instead of Treatment for Localized Prostate Cancer

Contrary to some news headlines, monitoring prostate cancer has different survival implications than treatment after 10 years.

The Next Frontier: Radiotherapy Plus Immunotherapy for Melanoma Brain Metastases

The Next Frontier: Radiotherapy Plus Immunotherapy for Melanoma Brain Metastases

The combination of radiotherapy and immunotherapy for brain metastases is promising, though toxicity and timing are poorly-understood factors.

Defibrotide for Hepatic Sinusoidal Obstruction Syndrome in Hematopoietic Stem Cell Transplant

Defibrotide for Hepatic Sinusoidal Obstruction Syndrome in Hematopoietic Stem Cell Transplant

Hepatic sinusoidal obstruction syndrome is a challenging post-hematopoietic cell transplantation condition to both diagnose and to treat.

Q&A With Samanta Kumar Pal, MD: Prostate Cancer Androgen Deprivation and "Drug Holidays"

Q&A With Samanta Kumar Pal, MD: Prostate Cancer Androgen Deprivation and "Drug Holidays"

In this Q&A, CTA asked Dr Pal about the ongoing controversy, evidence base, and pivotal studies of intermittent versus continuous androgen deprivation therapy for prostate cancer.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters